Release Date: 02/06/14 11:34 Summary: US ADR PROGRAM LAUNCHED Price Sensitive: No Download Document 420.89KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%